Home | Coriolis Pharma

Featured news: Coriolis starts hosting exclusive webinars

In our first session, Scientific Advisor Prof. Jiskoot will speak about "Nucleic acid-based medicinal products: Formulation considerations".

Read More

About us

Coriolis is a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs and vaccines.

As a privately-held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients.

Formulation Development

Formulation Development

“It is a medicine, not a molecule, that we are giving to the patient” Marc B. Brown, 2005.

Coriolis is the expert in developing liquid and lyophilized formulations for a large variety of different (bio)pharmaceutical molecules, including proteins, peptides, nucleic acids, ATMPs, GMOs, vaccines and virus(-like) particles.

Find out how we can support your drug development...

Read more

Analytical Services

Analytical Services

A highly diverse analytical portfolio entirely performed in-house: This is Coriolis.

With the latest in technology and highly experienced scientists, we are a trendsetter in the field. We provide our analytical services for samples up to biosafety level S2 under R&D and cGMP conditions, including method development, qualification and validation.

Get to know our services...

Read more

About us

About us

Independent, reliable and always on the cutting edge of science. Coriolis is a leading service provider for formulation research and development of (bio)pharmaceutical drugs and vaccines.

Get to know us...

Read more

Latest news

Coriolis Pharma expands its ATMP development facilities

Coriolis Pharma expands its ATMP development facilities

Constructions of new facilities for ATMP formulation development up to biosafety level S2 are in progress and operations are expected to start by Q4 2021

Prof. Ernst Wagner joins Coriolis Pharma’s Scientific Advisory Board

Prof. Ernst Wagner joins Coriolis Pharma’s Scientific Advisory Board as expert for nucleic acid therapeutics

We welcome Prof. Dr. Ernst Wagner as new Scientific Advisory Board Member and expert for nucleic acid therapeutics

Coriolis CSO and Scientific Advisor give key talks at international conference

Coriolis CSO and Scientific Advisor give key talks at international conference

Dr. Hawe & Prof. Kersten are invited speakers at the 12th Annual Biologics Formulation & Drug Delivery Forum

Gordon Research Conference invites Coriolis CTO as session chair

Gordon Research Conference invites Coriolis CTO as session chair

Dr. Tim Menzen will chair the session "Properties of Biologics Impacting Safety and Efficacy"

PhD Prize

Coriolis Scientist receives PhD Award for Thesis about Protein Aggregation

We congratulate Dr. Lorenzo Gentiluomo for his great achievement!

Prof. Dr. Gideon Kersten Scientific Advisor to Coriolis Pharma

Prof. Dr. Gideon Kersten joins Scientific Advisory Board of Coriolis

Prof. Kersten brings 35+ years of experience in vaccine development with a focus on characterization & formulation.

PhD Prize

Coriolis Scientist wins Prize for PhD Thesis about Freeze-drying

We congratulate Dr. Brecht Vanbillemont for his great achievement!

ThermoFisher Charged Aerosol Detection CAD

Coriolis Group Leader gives Talk at ThermoFisher CAD Symoposium

Dr. Georg Schuster discusses the investigation of polysorbate degradation.

Lyophilization Process Development Heat Flux Sensor

Lyophilization Process Development at Light-Speed

Novel approach obtains optimal process parameters with only one experimental run

Virtual meeting

Coriolis Scientist speaks at virtual CASSS Higher Order Structure Event

Dr. Constanze Helbig will talk about high-throughput analysis of subvisible particles

Latest publications

Comparison of Different Liquid Chromatography-Based Purification Strategies for Adeno-Associated Virus Vectors

Ruth Rieser, Johanna Koch, Greta Faccioli, Klaus Richter, Tim Menzen, Martin Biel, Gerhard Winter, Stylianos Michalakis

Combining Unfolding Reversibility Studies and Molecular Dynamics Simulations to Select Aggregation-Resistant Antibodies

Berner C, Menzen T, Winter G, Svilenov HL.

mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability

Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, Crommelin DJA

Oil-Immersion Flow Imaging Microscopy for Quantification and Morphological Characterization of Submicron Particles in Biopharmaceuticals

Krause N, Kuhn S, Frotscher E, Nikels F, Hawe A, Garidel P, Menzen T.

Immunological Evaluation In Vitro of Nanoparticulate Impurities Isolated From Pharmaceutical-Grade Sucrose

Grabarek A, Nabhan M, Turbica I, Hawe A, Pallardy M, Jiskoot W.

Simultaneous automated image analysis and Raman spectroscopy of powders at an individual particle level

Sekulovic A, Verrijk R, Rades T, Grabarek A, Jiskoot W, Hawe A and Rantanen J.

Advanced Therapy Medicinal Products: What's in a Name?

Jiskoot W.

Micelle driven oxidation mechanism and novel oxidation markers for different grades of polysorbate 20 and 80

Kranz W, Wuchner K, Corradini E, Menzen T, Hawe A.

Particulate impurities in cell-based medicinal products traced by flow imaging microscopy combined with deep learning for image analysis

Grabarek AD, Senel E, Menzen T, Hoodendoorn KH, Pike-Overzet K, Hawe A, Jiskoot W.

Heat Flux Sensor to Create a Design Space for Freeze-Drying Development

Marco Carfagna, Monica Rosa, Matthias Lucke, Andrea Hawe, Wolfgang Frieß